Mayuko Yamamoto
Overview
Explore the profile of Mayuko Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagata D, Takashi Y, Yamamoto M, Toyokawa K, Makihata K, Koganemaru H, et al.
Intern Med
. 2025 Mar;
PMID: 40058863
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that results from tumors that secrete fibroblast growth factor 23 (FGF23). This leads to chronic hypophosphatemia. Burosumab, an anti-FGF23 antibody, is an...
2.
Kambe N, Yamamoto M, Takemura K, Kagami S, Kawahara Y, Yoshifuji H, et al.
Allergol Int
. 2024 Dec;
PMID: 39690084
Background: Schnitzler syndrome is an adult-onset autoinflammatory disease characterized by an urticaria-like rash and monoclonal gammopathy with fever and fatigue. Although some treatments have shown efficacy in clinical trials, no...
3.
Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma
Yamamoto M, Nakajima K, Matsuda M, Takahashi A, Nakai K
Pediatr Dermatol
. 2024 Dec;
PMID: 39659052
This is the first report of pediatric linear scleroderma successfully treated with the topical Janus kinase (JAK) inhibitor delgocitinib. JAK inhibitors targeting the JAK/STAT pathway have been used to treat...
4.
Otomo A, Wiemann J, Bhattacharyya S, Yamamoto M, Yu Y, Iino R
Nano Lett
. 2024 Nov;
24(49):15638-15644.
PMID: 39573818
Understanding the function of rotary molecular motors, such as rotary ATPases, relies on our ability to visualize single-molecule rotation. Traditional imaging methods often involve tagging those motors with nanoparticles (NPs)...
5.
Inubushi S, Kunihisa T, Kuniyasu M, Inoue S, Yamamoto M, Yamashita Y, et al.
Cancer Genomics Proteomics
. 2024 Oct;
21(6):580-584.
PMID: 39467625
Background/aim: Exosomes are extracellular vesicles produced by both normal and cancer cells. Previous research has demonstrated that circulating exosomes derived from cancer cells may create a niche for future metastasis,...
6.
Matsuda M, Nakajima K, Aoki N, Yamamoto M, Nakajima H, Yamamoto H, et al.
J Dermatol
. 2024 Sep;
52(3):e225-e226.
PMID: 39349357
No abstract available.
7.
Otomo A, Wiemann J, Bhattacharyya S, Yamamoto M, Yu Y, Iino R
bioRxiv
. 2024 Sep;
PMID: 39229122
Understanding the function of rotary molecular motors, such as the rotary ATPases, relies on our ability to visualize the single-molecule rotation. Traditional imaging methods often involve tagging those motors with...
8.
Sano S, Yamamoto M, Kamijima R, Sano H
J Dermatol
. 2024 Apr;
51(9):e293-e295.
PMID: 38558035
No abstract available.
9.
Morisaka H, Sano H, Yamamoto M, Takaishi M, Nakajima H, Ogasawara F, et al.
J Eur Acad Dermatol Venereol
. 2024 Feb;
38(10):e846-e849.
PMID: 38421052
No abstract available.
10.
Mizumoto S, Inubushi S, Miki M, Nakamura H, Baba M, Yamashita Y, et al.
Anticancer Res
. 2023 Nov;
43(11):5067-5072.
PMID: 37909966
Background/aim: Breast cancer that is estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor-2 (HER2)-negative is termed triple-negative breast cancer (TNBC). Cytotoxic chemotherapy remains the first choice...